Articular involvement in juvenile localized scleroderma [PDF]
Osminina Mk, Geppe NA, Shpitonkova OV
openalex +3 more sources
High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma [PDF]
Motoshi Sonoda+6 more
openalex +2 more sources
Juvenile eosinophilic fasciitis: a single center case series [PDF]
Background Eosinophilic fasciitis (EF) is a rare disease characterized by skin induration and musculoskeletal abnormalities. Diagnostic criteria for EF are based on adult populations.
Leigh A. Stubbs+9 more
doaj +2 more sources
PReS-FINAL-2128: Quality of life and psychosocial aspects in juvenile localized scleroderma (JLS): a cross-sectional study in 40 patients [PDF]
Culpo R+5 more
europepmc +3 more sources
Juvenile-onset localized scleroderma activity detection by infrared thermography [PDF]
The aim of this study was to define the clinical utility of infrared thermography in disease activity detection in localized scleroderma (LS).We retrospectively reviewed 130 thermal images of 40 children with LS and calculated the sensitivity and specificity of thermography, comparing clinical descriptions of the lesions and contemporary thermographs ...
Giorgia Martini
openalex +5 more sources
SHARE – workpackage 5: evidence based recommendations for diagnosis and treatment of juvenile localized scleroderma and juvenile systemic sclerosis [PDF]
Culpo R+19 more
europepmc +3 more sources
Peripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles. [PDF]
Torok KS+7 more
europepmc +3 more sources
Juvenile Localized Scleroderma: A Very Rare Case
Juvenile localized scleroderma (JLS) is a rare chronic inflammatory and fibrosing disorder. It can result in significant morbidity, disfigurement, and severe functional, aesthetic and psychological disabilities. Patients with JLS should be identified early, evaluated extensively, treated aggressively, and monitored carefully.
Nibedita Paul+4 more
openalex +4 more sources
Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma [PDF]
Hanna Lythgoe+5 more
openalex +2 more sources